Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_assertion description "[The API2 gene, an inhibitor of apoptosis, and the novel MLT gene have been found to be altered by the t(11;18)(q21;21), which represents the most frequent structural chromosomal abnormality in extranodal low-grade MALT lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_assertion evidence source_evidence_literature NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_assertion SIO_000772 10797525 NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_assertion wasDerivedFrom befree-20140225 NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_assertion wasGeneratedBy ECO_0000203 NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP174509.RA3F6-N5403hALszhkxVuBkHuIwl3TySeZLv8u6Gm9nUs130_provenance.